BBC
05/08/2021, 00:05:04
Author Profile | Edit
|
All the Western media and their big Pharma kept harping to the Brazil data. Yes, the same Brazil data which you are also harping about. The Brazil trial focused on test subjects who were medical personnel working in high risk COVID-19 wards and were subjected to high doses of COVID-19 regularly. When you include the test subjects with confirmed COVID-19 but asymptomatic, the efficacy rate climbs above 70%. 100% of the test subjects didn't require serous hospitalization. The BioNtech Pfizer trial focused on the general population as test subjects and the efficacy was claimed to be 95%. Yes no one used Turkey's and the UAE's trial data which showed an efficacy rate of over 80% for Sinovac. So please stop harping on Sinovac's efficacy of 50% when you know it's not apples to apples when comparing trial data amongst vaccines.
|